Mechanisms of immune evasion by head and neck cancer stem cells

被引:10
作者
Xavier, Flavia Calo Aquino [1 ]
Silva, Jamerson Carvalho [1 ]
Rodini, Camila Oliveira [2 ]
Rodrigues, Maria Fernanda Setubal Destro [3 ]
机构
[1] Univ Fed Bahia, Sch Dent, Lab Oral Surg Pathol, Salvador, BA, Brazil
[2] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Sao Paulo, SP, Brazil
[3] Nove Julho Univ UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP, Brazil
来源
FRONTIERS IN ORAL HEALTH | 2022年 / 3卷
关键词
head and neck squamous cell carcinoma (HNSCC); cancer stem cell (CSC); immune surveillance; immune evasion; immunotherapy; CARCINOMA; EXPRESSION; CHEMORESISTANCE; IMMUNOTHERAPY; IMMUNOLOGY; BMI1;
D O I
10.3389/froh.2022.957310
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Different mechanisms are involved in immune escape surveillance driven by Oral and Head and Neck Cancer Stem Cells (HNCSCs). The purpose of this review is to show the most current knowledge regarding the main impact of HNCSCs on tumor evasion through immunosuppression, CSCs phenotypes and environmental signals, highlighting strategies to overcome immune evasion. The main results drive the participation of cell surface receptors and secreted products and ligands, the crosstalk between cells, and genetic regulation. The reduction in CD8(+) T cell recruitment and decreased effector of anti-PD-1 therapy by cells expressing BMI1 is a key event; Natural Killer cell ligands and cytokines needed for its activation and expansion are crucial to control tumor growth and to target CSCs by immunotherapy; CSCs expressing ALDH1 are related to increased expression of PD-L1, with a positive link between DNMT3b expression; CD276 expression in CSCs can act as a checkpoint inhibitor and together with Activator Protein 1 (AP-1) activation, they create continuous positive feedback that enables immune evasion by suppressing CD8+ T cells and prevent immune cell infiltration in head and neck cancer. These data demonstrate the relevance of the better understanding of the interaction between HNCSCs and immune cells in the tumor microenvironment. The ultimate clinical implication is to ground the choice of optimized targets and improve immune recognition for ongoing treatments as well as the response to approved immunotherapies.
引用
收藏
页数:9
相关论文
共 42 条
[1]   Cancer stem cells and tumor immunoediting: putting two and two together [J].
Bhatia, Alka ;
Kumar, Yashwant .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (06) :605-607
[2]   Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? [J].
Bruttel, Valentin S. ;
Wischhusen, Joerg .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[3]   Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma [J].
Chen, Demeng ;
Wu, Mansi ;
Li, Yang ;
Chang, Insoon ;
Yuan, Quan ;
Ekimyan-Salvo, Mari ;
Deng, Peng ;
Yu, Bo ;
Yu, Yongxin ;
Dong, Jiaqiang ;
Szymanski, John M. ;
Ramadoss, Sivakumar ;
Li, Jiong ;
Wang, Cun-Yu .
CELL STEM CELL, 2017, 20 (05) :621-+
[4]   Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer [J].
Cillo, Anthony R. ;
Kuerten, Cornelius H. L. ;
Tabib, Tracy ;
Qi, Zengbiao ;
Onkar, Sayali ;
Wang, Ting ;
Liu, Angen ;
Duvvuri, Umamaheswar ;
Kim, Seungwon ;
Soose, Ryan J. ;
Oesterreich, Steffi ;
Chen, Wei ;
Lafyatis, Robert ;
Bruno, Tullia C. ;
Ferris, Robert L. ;
Vignali, Dario A. A. .
IMMUNITY, 2020, 52 (01) :183-+
[5]   The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) [J].
Cohen, Ezra E. W. ;
Bell, R. Bryan ;
Bifulco, Carlo B. ;
Burtness, Barbara ;
Gillison, Maura L. ;
Harrington, Kevin J. ;
Quynh-Thu Le ;
Lee, Nancy Y. ;
Leidner, Rom ;
Lewis, Rebecca L. ;
Licitra, Lisa ;
Mehanna, Hisham ;
Mel, Loren K. ;
Raben, Adam ;
Sikora, Andrew G. ;
Uppaluri, Ravindra ;
Whitworth, Fernanda ;
Zandberg, Dan P. ;
Ferris, Robert L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[6]   Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma [J].
Fan, Qing-Min ;
Jing, Ying-Ying ;
Yu, Guo-Feng ;
Kou, Xing-Rui ;
Ye, Fei ;
Gao, Lu ;
Li, Rong ;
Zhao, Qiu-Dong ;
Yang, Yang ;
Lu, Zheng-Hua ;
Wei, Li-Xin .
CANCER LETTERS, 2014, 352 (02) :160-168
[7]   Cancer statistics for the year 2020: An overview [J].
Ferlay, Jacques ;
Colombet, Murielle ;
Soerjomataram, Isabelle ;
Parkin, Donald M. ;
Pineros, Marion ;
Znaor, Ariana ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (04) :778-789
[8]   Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J].
Ferris, R. L. ;
Blumenschein, G., Jr. ;
Fayette, J. ;
Guigay, J. ;
Colevas, A. D. ;
Licitra, L. ;
Harrington, K. ;
Kasper, S. ;
Vokes, E. E. ;
Even, C. ;
Worden, F. ;
Saba, N. F. ;
Iglesias Docampo, L. C. ;
Haddad, R. ;
Rordorf, T. ;
Kiyota, N. ;
Tahara, M. ;
Monga, M. ;
Lynch, M. ;
Geese, W. J. ;
Kopit, J. ;
Shaw, J. W. ;
Gillison, M. L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1856-1867
[9]   Immunology and Immunotherapy of Head and Neck Cancer [J].
Ferris, Robert L. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) :3293-+
[10]   The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure [J].
Galassi, Claudia ;
Musella, Martina ;
Manduca, Nicoletta ;
Maccafeo, Ester ;
Sistigu, Antonella .
CELLS, 2021, 10 (09)